Annual Revenue
$1.54 B
-$16.09 M-1.03%
December 31, 2023
Summary
- As of February 26, 2025, IART annual revenue is $1.54 billion, with the most recent change of -$16.09 million (-1.03%) on December 31, 2023.
- During the last 3 years, IART annual revenue has risen by +$169.71 million (+12.37%).
- IART annual revenue is now -1.03% below its all-time high of $1.56 billion, reached on December 31, 2022.
Performance
IART Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$380.83 M
-$37.34 M-8.93%
September 30, 2024
Summary
- As of February 26, 2025, IART quarterly revenue is $380.83 million, with the most recent change of -$37.34 million (-8.93%) on September 30, 2024.
- Over the past year, IART quarterly revenue has dropped by -$1.59 million (-0.41%).
- IART quarterly revenue is now -8.93% below its all-time high of $418.18 million, reached on June 30, 2024.
Performance
IART Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$1.56 B
-$1.59 M-0.10%
September 30, 2024
Summary
- As of February 26, 2025, IART TTM revenue is $1.56 billion, with the most recent change of -$1.59 million (-0.10%) on September 30, 2024.
- Over the past year, IART TTM revenue has increased by +$22.36 million (+1.45%).
- IART TTM revenue is now -0.12% below its all-time high of $1.57 billion, reached on June 30, 2022.
Performance
IART TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IART Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -1.0% | -0.4% | +1.4% |
3 y3 years | +12.4% | -0.4% | +1.4% |
5 y5 years | +4.7% | -0.4% | +1.4% |
IART Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1.0% | at low | -8.9% | +3.2% | -0.1% | +2.3% |
5 y | 5-year | -1.0% | +12.4% | -8.9% | +47.2% | -0.1% | +14.1% |
alltime | all time | -1.0% | >+9999.0% | -8.9% | >+9999.0% | -0.1% | >+9999.0% |
Integra LifeSciences Holdings Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $380.83 M(-8.9%) | $1.56 B(-0.1%) |
Jun 2024 | - | $418.18 M(+13.4%) | $1.57 B(+2.4%) |
Mar 2024 | - | $368.87 M(-7.1%) | $1.53 B(-0.8%) |
Dec 2023 | $1.54 B(-1.0%) | $397.04 M(+3.8%) | $1.54 B(-0.1%) |
Sep 2023 | - | $382.42 M(+0.3%) | $1.54 B(-0.2%) |
Jun 2023 | - | $381.27 M(+0.1%) | $1.55 B(-1.1%) |
Mar 2023 | - | $380.85 M(-4.3%) | $1.56 B(+0.3%) |
Dec 2022 | $1.56 B(+1.0%) | $398.02 M(+3.3%) | $1.56 B(-0.5%) |
Sep 2022 | - | $385.19 M(-3.2%) | $1.57 B(-0.1%) |
Jun 2022 | - | $397.81 M(+5.6%) | $1.57 B(+0.5%) |
Mar 2022 | - | $376.64 M(-7.1%) | $1.56 B(+1.1%) |
Dec 2021 | $1.54 B(+12.4%) | $405.52 M(+4.8%) | $1.54 B(+1.1%) |
Sep 2021 | - | $386.86 M(-0.8%) | $1.53 B(+1.1%) |
Jun 2021 | - | $389.99 M(+8.3%) | $1.51 B(+9.5%) |
Mar 2021 | - | $360.07 M(-7.4%) | $1.38 B(+0.4%) |
Dec 2020 | $1.37 B(-9.6%) | $388.65 M(+5.0%) | $1.37 B(-0.5%) |
Sep 2020 | - | $370.23 M(+43.1%) | $1.38 B(-0.6%) |
Jun 2020 | - | $258.67 M(-27.0%) | $1.39 B(-8.3%) |
Mar 2020 | - | $354.32 M(-10.3%) | $1.51 B(-0.4%) |
Dec 2019 | $1.52 B(+3.1%) | $395.13 M(+4.2%) | $1.52 B(+0.8%) |
Sep 2019 | - | $379.10 M(-1.2%) | $1.51 B(+0.9%) |
Jun 2019 | - | $383.64 M(+6.7%) | $1.49 B(+1.2%) |
Mar 2019 | - | $359.69 M(-6.2%) | $1.48 B(+0.2%) |
Dec 2018 | $1.47 B(+23.9%) | $383.31 M(+4.8%) | $1.47 B(+1.0%) |
Sep 2018 | - | $365.85 M(-0.1%) | $1.46 B(+6.3%) |
Jun 2018 | - | $366.19 M(+2.6%) | $1.37 B(+6.5%) |
Mar 2018 | - | $357.08 M(-3.1%) | $1.29 B(+8.3%) |
Dec 2017 | $1.19 B(+19.8%) | $368.60 M(+32.2%) | $1.19 B(+10.5%) |
Sep 2017 | - | $278.83 M(-1.2%) | $1.08 B(+2.7%) |
Jun 2017 | - | $282.16 M(+9.1%) | $1.05 B(+3.2%) |
Mar 2017 | - | $258.64 M(+1.2%) | $1.01 B(+2.2%) |
Dec 2016 | $992.08 M(+12.4%) | $255.66 M(+2.1%) | $992.08 M(+1.5%) |
Sep 2016 | - | $250.33 M(+0.4%) | $977.57 M(+2.5%) |
Jun 2016 | - | $249.31 M(+5.3%) | $953.61 M(+4.0%) |
Mar 2016 | - | $236.77 M(-1.8%) | $916.97 M(+3.9%) |
Dec 2015 | $882.73 M(+10.8%) | $241.16 M(+6.5%) | $882.73 M(+2.6%) |
Sep 2015 | - | $226.37 M(+6.4%) | $860.65 M(+3.5%) |
Jun 2015 | - | $212.67 M(+5.0%) | $831.80 M(-2.2%) |
Mar 2015 | - | $202.53 M(-7.5%) | $850.48 M(-1.5%) |
Dec 2014 | $796.72 M(+14.3%) | $219.07 M(+10.9%) | $863.01 M(+19.0%) |
Sep 2014 | - | $197.52 M(-14.6%) | $725.32 M(-2.1%) |
Jun 2014 | - | $231.35 M(+7.6%) | $741.04 M(+3.6%) |
Mar 2014 | - | $215.06 M(+164.2%) | $715.24 M(+2.6%) |
Dec 2013 | $696.83 M(-16.1%) | $81.39 M(-61.8%) | $696.83 M(-16.0%) |
Sep 2013 | - | $213.25 M(+3.7%) | $829.88 M(+0.4%) |
Jun 2013 | - | $205.55 M(+4.5%) | $826.72 M(-0.6%) |
Mar 2013 | - | $196.65 M(-8.3%) | $831.34 M(+0.1%) |
Dec 2012 | $830.87 M(+6.5%) | $214.43 M(+2.1%) | $830.87 M(+1.3%) |
Sep 2012 | - | $210.08 M(-0.0%) | $819.96 M(+1.0%) |
Jun 2012 | - | $210.17 M(+7.1%) | $812.06 M(+2.1%) |
Mar 2012 | - | $196.19 M(-3.6%) | $795.22 M(+1.9%) |
Dec 2011 | $780.08 M(+6.6%) | $203.52 M(+0.7%) | $780.08 M(+1.2%) |
Sep 2011 | - | $202.19 M(+4.6%) | $770.69 M(+2.1%) |
Jun 2011 | - | $193.33 M(+6.8%) | $755.14 M(+2.0%) |
Mar 2011 | - | $181.04 M(-6.7%) | $740.41 M(+1.1%) |
Dec 2010 | $732.07 M(+7.3%) | $194.13 M(+4.0%) | $732.07 M(+1.5%) |
Sep 2010 | - | $186.64 M(+4.5%) | $721.46 M(+2.0%) |
Jun 2010 | - | $178.59 M(+3.4%) | $707.11 M(+1.9%) |
Mar 2010 | - | $172.70 M(-5.9%) | $694.24 M(+1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | $682.49 M(+4.3%) | $183.53 M(+6.5%) | $682.49 M(+1.4%) |
Sep 2009 | - | $172.29 M(+4.0%) | $673.33 M(+0.8%) |
Jun 2009 | - | $165.72 M(+3.0%) | $668.07 M(+1.3%) |
Mar 2009 | - | $160.95 M(-7.7%) | $659.55 M(+0.8%) |
Dec 2008 | $654.60 M(+18.9%) | $174.37 M(+4.4%) | $654.60 M(+2.6%) |
Sep 2008 | - | $167.03 M(+6.3%) | $637.88 M(+5.3%) |
Jun 2008 | - | $157.20 M(+0.8%) | $605.87 M(+3.8%) |
Mar 2008 | - | $156.01 M(-1.0%) | $583.43 M(+6.0%) |
Dec 2007 | $550.46 M(+31.3%) | $157.65 M(+16.8%) | $550.46 M(+6.2%) |
Sep 2007 | - | $135.01 M(+0.2%) | $518.21 M(+3.7%) |
Jun 2007 | - | $134.77 M(+9.5%) | $499.84 M(+7.4%) |
Mar 2007 | - | $123.03 M(-1.9%) | $465.19 M(+10.9%) |
Dec 2006 | $419.30 M(+50.9%) | $125.39 M(+7.5%) | $419.30 M(+14.3%) |
Sep 2006 | - | $116.65 M(+16.5%) | $366.89 M(+14.8%) |
Jun 2006 | - | $100.12 M(+29.8%) | $319.57 M(+10.5%) |
Mar 2006 | - | $77.14 M(+5.7%) | $289.23 M(+4.1%) |
Dec 2005 | $277.94 M(+20.9%) | $72.98 M(+5.3%) | $277.94 M(+4.2%) |
Sep 2005 | - | $69.33 M(-0.6%) | $266.76 M(+4.0%) |
Jun 2005 | - | $69.78 M(+6.0%) | $256.56 M(+5.5%) |
Mar 2005 | - | $65.84 M(+6.5%) | $243.22 M(+5.8%) |
Dec 2004 | $229.82 M(+23.8%) | $61.81 M(+4.5%) | $229.82 M(+1.2%) |
Sep 2004 | - | $59.13 M(+4.8%) | $227.04 M(+5.6%) |
Jun 2004 | - | $56.44 M(+7.6%) | $214.97 M(+6.8%) |
Mar 2004 | - | $52.44 M(-11.2%) | $201.26 M(+8.4%) |
Dec 2003 | $185.60 M(+64.8%) | $59.02 M(+25.4%) | $185.60 M(+18.5%) |
Sep 2003 | - | $47.06 M(+10.1%) | $156.64 M(+12.1%) |
Jun 2003 | - | $42.74 M(+16.2%) | $139.78 M(+13.2%) |
Mar 2003 | - | $36.78 M(+22.3%) | $123.49 M(+9.6%) |
Dec 2002 | $112.63 M(+28.4%) | $30.06 M(-0.5%) | $112.63 M(+6.0%) |
Sep 2002 | - | $30.20 M(+14.2%) | $106.26 M(+8.0%) |
Jun 2002 | - | $26.44 M(+2.0%) | $98.38 M(+5.4%) |
Mar 2002 | - | $25.92 M(+9.4%) | $93.32 M(+4.8%) |
Dec 2001 | $87.69 M(+34.9%) | $23.70 M(+6.2%) | $89.09 M(+5.3%) |
Sep 2001 | - | $22.32 M(+4.4%) | $84.56 M(+6.9%) |
Jun 2001 | - | $21.39 M(-1.4%) | $79.14 M(+7.6%) |
Mar 2001 | - | $21.68 M(+13.1%) | $73.58 M(+10.8%) |
Dec 2000 | $64.99 M(+62.3%) | $19.18 M(+13.5%) | $66.42 M(+15.1%) |
Sep 2000 | - | $16.89 M(+6.7%) | $57.70 M(+9.1%) |
Jun 2000 | - | $15.83 M(+8.9%) | $52.91 M(+6.5%) |
Mar 2000 | - | $14.53 M(+39.1%) | $49.68 M(+23.7%) |
Dec 1999 | $40.05 M(+182.4%) | $10.45 M(-13.7%) | $40.15 M(+28.8%) |
Sep 1999 | - | $12.10 M(-4.0%) | $31.18 M(+33.4%) |
Jun 1999 | - | $12.60 M(+152.0%) | $23.38 M(+60.3%) |
Mar 1999 | - | $5.00 M(+237.4%) | $14.58 M(+2.8%) |
Dec 1998 | $14.18 M(-3.5%) | $1.48 M(-65.5%) | $14.18 M(-11.4%) |
Sep 1998 | - | $4.30 M(+13.2%) | $16.00 M(+2.6%) |
Jun 1998 | - | $3.80 M(-17.4%) | $15.60 M(-3.1%) |
Mar 1998 | - | $4.60 M(+39.4%) | $16.10 M(+9.5%) |
Dec 1997 | $14.70 M(+12.2%) | $3.30 M(-15.4%) | $14.70 M(-3.3%) |
Sep 1997 | - | $3.90 M(-9.3%) | $15.20 M(+7.0%) |
Jun 1997 | - | $4.30 M(+34.4%) | $14.20 M(+6.0%) |
Mar 1997 | - | $3.20 M(-15.8%) | $13.40 M(+0.8%) |
Dec 1996 | $13.10 M(+28.4%) | $3.80 M(+31.0%) | $13.30 M(+6.4%) |
Sep 1996 | - | $2.90 M(-17.1%) | $12.50 M(+2.5%) |
Jun 1996 | - | $3.50 M(+12.9%) | $12.20 M(+10.9%) |
Mar 1996 | - | $3.10 M(+3.3%) | $11.00 M(+7.8%) |
Dec 1995 | $10.20 M | $3.00 M(+15.4%) | $10.20 M(+41.7%) |
Sep 1995 | - | $2.60 M(+13.0%) | $7.20 M(+56.5%) |
Jun 1995 | - | $2.30 M(0.0%) | $4.60 M(+100.0%) |
Mar 1995 | - | $2.30 M | $2.30 M |
FAQ
- What is Integra LifeSciences Holdings annual revenue?
- What is the all time high annual revenue for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual revenue year-on-year change?
- What is Integra LifeSciences Holdings quarterly revenue?
- What is the all time high quarterly revenue for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly revenue year-on-year change?
- What is Integra LifeSciences Holdings TTM revenue?
- What is the all time high TTM revenue for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM revenue year-on-year change?
What is Integra LifeSciences Holdings annual revenue?
The current annual revenue of IART is $1.54 B
What is the all time high annual revenue for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual revenue is $1.56 B
What is Integra LifeSciences Holdings annual revenue year-on-year change?
Over the past year, IART annual revenue has changed by -$16.09 M (-1.03%)
What is Integra LifeSciences Holdings quarterly revenue?
The current quarterly revenue of IART is $380.83 M
What is the all time high quarterly revenue for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly revenue is $418.18 M
What is Integra LifeSciences Holdings quarterly revenue year-on-year change?
Over the past year, IART quarterly revenue has changed by -$1.59 M (-0.41%)
What is Integra LifeSciences Holdings TTM revenue?
The current TTM revenue of IART is $1.56 B
What is the all time high TTM revenue for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM revenue is $1.57 B
What is Integra LifeSciences Holdings TTM revenue year-on-year change?
Over the past year, IART TTM revenue has changed by +$22.36 M (+1.45%)